PHGE
PHGE
AMEX · Biotechnology

Biomx Inc

$4.49
-0.13 (-2.81%)
Financial Highlights (FY 2025)
Revenue
2.00M
Net Income
-74,230
Gross Margin
28.1%
Profit Margin
-3.7%
Rev Growth
+11.8%
D/E Ratio
0.69
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 28.1% 28.1% 28.1%
Operating Margin -4.1% -4.4% -5.1%
Profit Margin -3.7% -3.5% -3.9%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 2.00M 1.99M 1.61M
Gross Profit 561.9K 559.1K 452.9K
Operating Income -82,976 -88,139 -82,820
Net Income -74,230 -69,635 -62,110
Gross Margin 28.1% 28.1% 28.1%
Operating Margin -4.1% -4.4% -5.1%
Profit Margin -3.7% -3.5% -3.9%
Rev Growth +11.8% +24.3% -3.3%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 2.28M 2.17M 2.33M
Total Equity 3.28M 3.29M 2.83M
D/E Ratio 0.69 0.66 0.82
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -116,342 -139,946 -107,891
Free Cash Flow -67,743 -57,560 -72,298